Aditi Bhattacharya and Eric Klann http://www.ncbi.nlm.nih.gov/pubmed/22500622 ...
Fragile X syndrome therapeutics S(C)TEP through the developmental window
May 31, 2012
Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
October 22, 2012
The translation of translational control by FMRP: therapeutic targets for FXS
April 18, 2013
Jennifer C. Darnell, and Eric Klann http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3379.html De novo protein synthesis is necessary for long-lasting modifications in synaptic strength and dendritic spine dynamics that underlie cognition. Fragile X syndrome (FXS), characterized by intellectual disability...
(Li+)ghting the way for a treatment for cognitive impairments in fragile X syndrome
May 5, 2014